The Daily Gazette
In the Daily Gazette, Meg D. emphasizes that Pharmacy Benefit Managers (PBMs) continue to drive up drug costs and delay patient access to necessary treatments through rebate practices and fail-first policies that can worsen outcomes for people living with chronic diseases like polycystic kidney disease. Meg also warns that price control proposals like the Most Favored Nation model could threaten medical innovation and research, urging lawmakers to focus instead on stronger PBM accountability measures that protect both patient access and future cures.